RESUMO
All-trans retinoic acid (AR-t) is used for treating acute promyelocytic leukemia and renal cell carcinoma and it also has therapeutic value in several animal models of renal disease. Among its renal targets, mesangial cells have been widely studied: they have both retinoic acid receptors (RAR) and retinoid X receptors (RXR) and the cell growth is inhibited when human mesangial cells are incubated with 1-10 microM AR-t. Although his effect has been related with the antiproliferative action of AR-t, there are no studies on the involvement of apoptosis in AR-t induced cell growth when higher concentrations of retinoid are used. Our studies show that 25 microM AR-t triggers mesangial cell apoptosis assessed by light and fluorescence microscopy (Giemsa stain and acridine orange stain, respectively), DNA electrophoresis, flow cytometry (annexin-V) and immunocytochemistry (TUNEL). AR-t induced apoptosis was not inhibited by preincubation with the RXR pan-antagonist HX531 nor with the RAR pan-antagonist AGN 193109, this suggesting RAR and RXIR are not involved in AR-t induced cell death. Previous results of our group showed that ERK (extracellular regulated kinase) and INK (c-Jun kinase), two members of the MAP (mitogen activated protein) kinase family, are involved in non apoptotic effects of AR-t on mesangial cells. Therefore we focussed on the stress activated p38 kinase, the third member of the MAPK family, to investigate its involvement in AR-t induced apoptosis. The results confirmed a role of p38 since: 1) preincubation with B5203589, a p38 inhibitor, inhibited ARA induced apoptosis; 2) incubation with AR-t induced p38 phosphorilation after few minutes and p38 remained phosphorilated for at least 8 hours and 3) AR-t induced p38 phosphorilation was inhibited by SB203589. These data suggest that AR-t might have toxic side effects on the kidney but also suggest that AR-t could be an useful inhibitor of pathological mesangial cell expansion.
Assuntos
Apoptose/efeitos dos fármacos , Mesângio Glomerular/citologia , Tretinoína/farmacologia , Proteínas Quinases p38 Ativadas por Mitógeno/fisiologia , Células Cultivadas , HumanosRESUMO
In spite of the extensive potential of human mesenchymal stem cells (hMSCs) in cell therapy, little is known about the molecular mechanisms that regulate their therapeutic properties. We aimed to identify microRNAs (miRNAs) involved in controlling the transition between the resting and reparative phenotypes of hMSCs, hypothesizing that these miRNAs must be present in the undifferentiated cells and downregulated to allow initiation of distinct activation/differentiation programs. Differential miRNA expression analyses revealed that miR-335 is significantly downregulated upon hMSC differentiation. In addition, hMSCs derived from a variety of tissues express miR-335 at a higher level than human skin fibroblasts, and overexpression of miR-335 in hMSCs inhibited their proliferation and migration, as well as their osteogenic and adipogenic potential. Expression of miR-335 in hMSCs was upregulated by the canonical Wnt signaling pathway, a positive regulator of MSC self-renewal, and downregulated by interferon-γ (IFN-γ), a pro-inflammatory cytokine that has an important role in activating the immunomodulatory properties of hMSCs. Differential gene expression analyses, in combination with computational searches, defined a cluster of 62 putative target genes for miR-335 in hMSCs. Western blot and 3'UTR reporter assays confirmed RUNX2 as a direct target of miR-335 in hMSCs. These results strongly suggest that miR-335 downregulation is critical for the acquisition of reparative MSC phenotypes.
Assuntos
Diferenciação Celular , Movimento Celular/fisiologia , Regulação da Expressão Gênica/fisiologia , Células-Tronco Mesenquimais/metabolismo , MicroRNAs/biossíntese , Transdução de Sinais/fisiologia , Regiões 3' não Traduzidas/fisiologia , Subunidade alfa 1 de Fator de Ligação ao Core/genética , Subunidade alfa 1 de Fator de Ligação ao Core/metabolismo , Células HEK293 , Humanos , Interferon gama/genética , Interferon gama/metabolismo , Células-Tronco Mesenquimais/citologia , MicroRNAs/genética , Proteínas Wnt/genética , Proteínas Wnt/metabolismoRESUMO
In order to test recombinant Toxoplasma as adjuvant and live vaccine carrier in the infectious disease model of murine experimental leishmaniasis, we engineered the attenuated, temperature-sensitive Toxoplasma gondii strain ts-4 to express the heterologous Leishmania antigen kinetoplastid membrane protein-11 (KMP-11). Transgenic ts-4 clones were obtained which express KMP-11 as cytoplasmatic protein or target it to the secretory pathway of the tachyzoites. Immunization of BALB/c mice with these stably transformed parasites elicited proliferative responses to both T. gondii antigen and recombinant KMP-11. When challenged with Leishmania major, we observed significant protection in animals that had been vaccinated with the KMP-11-expressing ts-4 mutants. The adjuvant attenuated only the onset of the Leishmania infection, but animals were ultimately not able to control the disease. Thus, our findings demonstrate that recombinant Toxoplasma has the potential to serve as an efficient vaccine carrier for cutaneous leishmaniasis. Furthermore, they establish a protective role for the antigen KMP-11 when given in such a vaccine formulation.
Assuntos
Leishmania/imunologia , Glicoproteínas de Membrana/imunologia , Proteínas de Protozoários/imunologia , Vacinas Protozoárias/imunologia , Toxoplasma/genética , Vacinas Sintéticas/imunologia , Animais , Feminino , Leishmaniose/prevenção & controle , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Recombinantes/imunologia , Vacinação , Vacinas Atenuadas/imunologiaRESUMO
El ácido retinoico todo-trans (AR-t) se utiliza en clínica en el tratamiento de la leucemiapromielocítica aguda y el cáncer renal. También presenta efecto terapéutico endiversas formas de enfermedad renal experimental. Las células mesangiales son una delas dianas farmacológicas de AR-t mejor estudiadas: presentan receptores de ácido retinoico(RAR) y receptores X de retinoides (RXR) y el AR-t, a concentraciones entre 1 y 10µM, inhibe su crecimiento. Este efecto se ha relacionado con la acción antiproliferativadel AR-t, aunque no se ha estudiado la participación de mecanismos apoptóticos cuandose utilizan mayores concentraciones de AR-t. El presente trabajo demuestra que AR-t25 µM induce apoptosis de células mesangiales humanas en cultivo, caracterizada porestudios de microscopía óptica y de fluorescencia (tinciones de Giemsa y naranja deacridina, respectivamente), electroforesis del ADN fragmentado, citometría de flujo(anexina-V/ioduro de propidio) e inmunocitoquímica (TUNEL). Ni HX531 (pan-antagonistaRXR), ni AGN193109 (pan-antagonista RAR) redujeron el grado de muerte celularinducido por el AR-t, lo que sugiere un mecanismo independiente de receptores. Resultadosprevios de nuestro grupo indican que dos de los tres miembros de las quinasasactivadas por mitógenos (MAP), ERK (quinasa regulada por estímulos extracelulares) yJNK (quinasa de c-Jun), están implicados en efectos no apoptóticos del AR-t en célulasmesangiales. Nos centramos, pues, en el potencial pro-apoptótico del tercer miembro,la quinasa activada por estrés p38. Confirmamos su implicación en la apoptosis inducidapor el AR-t porque: 1) su inhibidor farmacológico, SB203580, previno dicha apoptosis2) El AR-t indujo en pocos minutos la fosforilación de p38, manteniéndose fosforiladadurante las 8 horas posteriores; y 3) dicha fosforilación se inhibió por preincubación conSB203580. Estos datos sugieren una posible toxicidad renal del AR-t, pero también suutilidad para controlar la proliferación patológica de células mesangiales
All-trans retinoic acid (AR-t) is used for treating acute promyelocytic leukemia andrenal cell carcinoma and it also has therapeutic value in several animal models of renaldisease. Among its renal targets, mesangial cells have been widely studied: they haveboth retinoic acid receptors (RAR) and retinoid X receptors (RXR) and the cell growthis inhibited when human mesangial cells are incubated with 1-10 µM AR-t. Althoughhis effect has been related with the antiproliferative action of AR-t, there are no studieson the involvement of apoptosis in AR-t induced cell growth when higher concentrationsof retinoid are used. Our studies show that 25 µM AR-t triggers mesangial cellapoptosis assessed by light and fluorescence microscopy (Giemsa stain and acridineorange stain, respectively), DNA electrophoresis, flow cytometry (annexin-V) andimmunocytochemistry (TUNEL). AR-t induced apoptosis was not inhibited by preincubationwith the RXR pan-antagonist HX531 nor with the RAR pan-antagonist AGN193109, this suggesting RAR and RXIR are not involved in AR-t induced cell death.Previous results of our group showed that ERK (extracellular regulated kinase) andJNK (c-Jun kinase), two members of the MAP (mitogen activated protein) kinasefamily, are involved in non apoptotic effects of AR-t on mesangial cells. Therefore wefocussed on the stress activated p38 kinase, the third member of the MAPK family, toinvestigate its involvement in AR-t induced apoptosis. The results confirmed a role ofp38 since: 1) preincubation with SB203589, a p38 inhibitor, inhibited ARA inducedapoptosis; 2) incubation with AR-t induced p38 phosphorilation after few minutesand p38 remained phosphorilated for at least 8 hours and 3) AR-t induced p38 phosphorilationwas inhibited by SB203589. These data suggest that AR-t migth have toxicside effects on the kidney but also suggest that AR-t could be an useful inhibitor of pathologicalmesangial cell expansion